Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RANOLAZINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for RANOLAZINE EXTENDED-RELEASE TABLETS.RANOLAZINE extended-release tablets, for oral useInitial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
Ranolazine extended-release tablet is indicated for the treatment of chronic angina. Ranolazine extended-release tablet may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
- generic_name
- ranolazine
- product_names
- Ranolazine
- ndc
- 70771-1499, 70771-1500, 70771-1499-6, 70771-1499-1, 70771-1499-5, 70771-1499-2, 70771-1499-4, 70771-1500-6, 70771-1500-1, 70771-1500-5, 70771-1500-2, 70771-1500-4
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en